rate contract for medicine - letrozole 2.5mg, ear drops, each ml containing polymixin b sulphate usp, 10000 units neomycin sulphate ip 3400 units, hyrdocortisone ip 10mg, i.v. dextrose 10%, vitamin k 1 mg/ml inj., prednisolone oral liquid 5 mg/5 ml usp, i.v. fluid (n/2+destrose 5%), imipramine tablet 75 mg ip, levodopa (a) + carbidopa (b) tablet 100 mg (a) + 25, mg (b) cr ip, zinc oxide with eugenol 15 mg + 10 ml, prednisolone sodium phosphate eds 1% 5ml, thiamine tablet 100 mg ip.

Punjab Health Systems Corporation has invited bids for the rate contract for medicine - letrozole 2.5mg, ear drops, each ml containing polymixin b sulphate usp, 10000 units neomycin sulphate ip 3400 units, hyrdocortisone ip 10mg, i.v. dextrose 10%, vitamin k 1 mg/ml inj., prednisolone oral liquid 5 mg/5 ml usp, i.v. fluid (n/2+destrose 5%), imipramine tablet 75 mg ip, levodopa (a) + carbidopa (b) tablet 100 mg (a) + 25, mg (b) cr ip, zinc oxide with eugenol 15 mg + 10 ml, prednisolone sodium phosphate eds 1% 5ml, thiamine tablet 100 mg ip.. Please refer to the tender document for project value and EMD details. Interested bidders can submit applications until 1 October 2026, with the technical opening scheduled for 1 October 2026.